The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9
Open Access
- 29 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8), e73219
- https://doi.org/10.1371/journal.pone.0073219
Abstract
Flavonoids have been reported to inhibit tumor growth by causing cell cycle arrest. However, little is known about the direct targets of flavonoids in tumor growth inhibition. In the present study, we developed a novel method using magnetic FG beads to purify flavonoid-binding proteins, and identified ribosomal protein S9 (RPS9) as a binding partner of the flavonoid apigenin. Similar to treatment with apigenin, knockdown of RPS9 inhibited the growth of human colon cancer cells at the G2/M phase by downregulating cyclin-dependent kinase 1 (CDK1) expression at the promoter level. Furthermore, knockdown of RPS9 suppressed G2/M arrest caused by apigenin. These results suggest that apigenin induces G2/M arrest at least partially by directly binding and inhibiting RPS9 which enhances CDK1 expression. We therefore raise the possibility that identification of the direct targets of flavonoids may contribute to the discovery of novel molecular mechanisms governing tumor growth.This publication has 45 references indexed in Scilit:
- Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targetsProceedings of the National Academy of Sciences of the United States of America, 2013
- Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1Cancer Prevention Research, 2011
- IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7Nature Immunology, 2011
- Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53European Journal of Cancer, 2010
- Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathwayCancer Letters, 2010
- Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 ActivationPLOS ONE, 2010
- Bacterial Effector Binding to Ribosomal Protein S3 Subverts NF-κB FunctionPLoS Pathogens, 2009
- How Common Are Extraribosomal Functions of Ribosomal Proteins?Molecular Cell, 2009
- Ribosomal Protein S9 Is a Novel B23/NPM-binding Protein Required for Normal Cell ProliferationOnline Journal of Public Health Informatics, 2008
- Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cellsCarcinogenesis: Integrative Cancer Research, 2008